| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.003 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |